Diversified Healthcare Trust (DHC) fair value analysis
Nasdaq · Updated 2026-10-19
DHC price how computed
Valuation status
No P/E-based verdictDHC: P/E-based fair value does not apply to REITs; their earnings are reported net of depreciation.
The price, fundamentals and dividend data below are unaffected.
- Last price
- $7.74
- Sector
- Real Estate
- 12-month range
- $4.10–$9.64
- Market cap
- $1.87B
- From 52-week high
- -19.7%
- Shares outstanding
- 242M
- Rank in Real Estate by quality score
- #43 of 45
Last price is the 2026-10-01 month-start close, the freshest stored price; the chart runs through 2026-10-16.
Diversified Healthcare Trust is a real estate investment trust that acquires, owns, and manages healthcare properties across the United States. The company's portfolio includes medical office buildings, senior housing facilities, and other healthcare-related real estate assets.
DHC currently ranks #43 of 45 Real Estate stocks by quality score.
Fundamentals (4 quarters) how computed
- Market cap
- $1.87B
- P/E (trailing)
- n/m
- Revenue (TTM)
- $1.5B
- Net margin
- -17.7%
- EPS (TTM)
- $-0.25
- Gross margin
- -11.1%
- Debt / equity
- 1.53
- Revenue growth (3-yr avg)
- 0.8%
- Shares outstanding
- 242M
Derived indicators how computed
- Quality grade
- F
- Margin trend
- Contracting
- 52-week position
- The upper-middle quarter of its range
Technicals how computed
- RSI (14-day)
- 35 · neutral
- 50-day average
- $7.88
- 200-day average
- $7.65
- Moving-average state
- 50-day above 200-day (golden cross state); price between the averages
Dividends how computed
- Paid, last 12 months
- $0.05 per share (5 payments)
- Yield on last price
- 0.65%
- Consecutive years of increases
- 0 (no streak on complete calendar years)
- Last ex-dividend date
- 2026-10-19
- Last payment date
- 2026-11-12
Earnings how computed
- Next earnings report
- 2026-11-02 (post-market)
- Last 8 quarters vs consensus
- 7 beat, 1 missed
- Quarter by quarter
- 2026-06 ▲ beat (+14.3%)
2026-03 ▲ beat (+18.8%)
2025-12 ▲ beat (+65.1%)
2025-09 ▲ beat (+4.3%)
2025-06 ▲ beat (+13.0%)
2025-03 ▲ beat (+14.3%)
2024-12 ▲ beat (+6.6%)
2024-09 ▼ miss (-58.4%)
Analyst consensus how computed
This is not TickrTrends' verdict.
- Analyst ratings
- 3 buy · 2 hold · 0 sell (5 analysts)
- Consensus lean
- Buy-leaning
- Consensus price target
- $10.2
- Target vs last price
- +31.8%
What our data shows for DHC
- Shares are trading in the middle of their 12-month price range of $4.10–$9.64.
- The 14-day relative strength index sits at a neutral 35.
What subscribers see
- Every published Forward Fair Value with its exact discount or premium
- The normalized P/E and quarter count behind each estimate
- Screeners and rankings across the full S&P 500 and Nasdaq universes
- DHC's own verdict the week it qualifies, published automatically
Forward Fair Value applies a conservatively normalized historical price-to-earnings multiple to the consensus earnings estimate for the next full fiscal year; how TickrTrends computes it.
What people are saying
Follow the DHC conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-10-19 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-12 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-11 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-10 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-05 — DHC is a real estate investment trust in the Real Estate sector. The valuation verdict changed this week from awaiting full valuation to no P/E-based verdict, reflecting the company's REIT status and the inapplicability of traditional P/E-based valuation metrics to this asset class.
- 2026-09-28 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.
Frequently asked questions
Is DHC stock undervalued?
TickrTrends publishes no fair-value verdict for DHC. P/E-based fair value does not apply to REITs; their earnings are reported net of depreciation.
What is DHC's TickrTrends verdict?
DHC is a REIT, so it is marked 'No P/E-based verdict'. Its price, fundamentals and dividend data are still shown and refreshed with every run.
How does DHC compare to other Real Estate stocks?
DHC ranks #43 of 45 Real Estate stocks in TickrTrends' coverage by quality score. It carries no fair-value verdict yet, so it is not ranked by discount.
Is DHC overbought or oversold?
DHC's 14-day RSI is in neutral territory - neither overbought nor oversold.
Does DHC pay a dividend?
Yes. DHC paid $0.05 per share over the last twelve months (5 payments), a 0.65% yield on TickrTrends' last price. The last ex-dividend date was 2026-10-19.
When does DHC report earnings next?
DHC's next earnings report is scheduled for 2026-11-02 (post-market), per the published earnings calendar.
Does DHC usually beat earnings estimates?
Over its last 8 reported quarters DHC beat the consensus estimate 7 times and missed 1 times, by TickrTrends' comparison of reported and estimated EPS.
What do analysts say about DHC?
Of 5 analysts covering DHC, 3 rate it a buy, 2 a hold and 0 a sell - buy-leaning, with a consensus price target of $10.2 (+31.8% versus TickrTrends' last price). This is the analyst consensus, not TickrTrends' Forward Fair Value verdict.
Other share classes
Also trades as DHCNL, another share class of Diversified Healthcare Trust. Our ranked lists show the company once, under DHC, its most liquid class.